Skip to main content
. 2021 Jul 15;14:867–875. doi: 10.2147/PGPM.S317229

Table 2.

Univariate Analysis of TP and SNPs in Olanzapine and Aprepitant Group

Polymorphism Olanzapine Regimen (n (%)) Aprepitant Regimen (n (%))
Acute Phase Delayed Phase Acute Phase Delayed Phase
rs1045642 TT 17 (94.4) 5 (27.8) 6 (100.0) 3 (50.0)
Non-TT 71 (93.4) 48 (63.2) 84 (92.3) 52 (57.1)
P 1.00 0.01 1.00 1.00
rs2032582 GG 27 (93.1) 17 (58.6) 23 (88.5) 9 (34.6)
Non-GG 61 (93.8) 36 (55.4) 67 (94.4) 46 (64.8)
P 0.27 0.77 0.38 0.01

Note: Only showed the significant data.